VEGFA Mouse Monoclonal Antibody [Clone ID: 4B2-8]

CAT#: AM01371PU-N

VEGFA mouse monoclonal antibody, clone 4B2-8, Azide Free



Need it in bulk or conjugated?
Get a free quote

CNY 3,630.00


货期*
5周

规格
    • 500 ug

Product images

Specifications

Product Data
Clone Name 4B2-8
Applications ELISA, WB
Recommend Dilution ELISA: In a Sandwich ELISA (assuming 100ul/well), a concentration of 2.0-4.0 μg/ml of this antibody will detect at least 100 pg/ml of recombinant Human VEGF165 when used with Biotin anti-Human VEGF165 antibody (Cat.-No PP1073B) as the detection antibody at a concentration of approximately 0.25-1.0 μg/ml.
Western Blot: To detect Human VEGF165 by Western Blot analysis this antibody can be used at a concentration of 0.25-0.50 μg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human VEGF165 is 0.25-0.50 ng/lane, under non-reducing conditions.
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen Highly pure (>98%) E.coli derived recombinant Human VEGF165 (Cat.-No PA136).
Specificity This antibody detects Vascular Endothelial Growth Factor. Other species not tested.
Formulation PBS without preservatives
State: Azide Free
State: Lyophilized (sterile filtered) purified IgG fraction from cell culture
Reconstitution Method Restore in sterile water to a concentration of 1.0 mg/ml.
Purification Affinity Chromatography on Protein A
Conjugation Unconjugated
Storage Condition Store lyophilized at 2-8°C for 6 months or at -20°C long term.
After reconstitution store the antibody undiluted at 2-8°C for one month
or (in aliquots) at -20°C long term.
Avoid repeated freezing and thawing.
Gene Name vascular endothelial growth factor A
Synonyms VEGFA, VEGF, VPF, Vascular endothelial growth factor A, Vascular permeability factor
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...